| pubmed-article:10342370 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10342370 | lifeskim:mentions | umls-concept:C0034493 | lld:lifeskim |
| pubmed-article:10342370 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
| pubmed-article:10342370 | lifeskim:mentions | umls-concept:C0023779 | lld:lifeskim |
| pubmed-article:10342370 | lifeskim:mentions | umls-concept:C0033262 | lld:lifeskim |
| pubmed-article:10342370 | lifeskim:mentions | umls-concept:C0070895 | lld:lifeskim |
| pubmed-article:10342370 | lifeskim:mentions | umls-concept:C1517572 | lld:lifeskim |
| pubmed-article:10342370 | lifeskim:mentions | umls-concept:C1656863 | lld:lifeskim |
| pubmed-article:10342370 | lifeskim:mentions | umls-concept:C0767952 | lld:lifeskim |
| pubmed-article:10342370 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:10342370 | pubmed:dateCreated | 1999-6-25 | lld:pubmed |
| pubmed-article:10342370 | pubmed:abstractText | To evaluate the intraocular distribution and metabolism of the lipid prodrug of foscarnet, 1-O-octadecyl-sn-glycerol-3- phosphonoformate (ODG-PFA), following intravitreal administration. | lld:pubmed |
| pubmed-article:10342370 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10342370 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10342370 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10342370 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10342370 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10342370 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10342370 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10342370 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10342370 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10342370 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10342370 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10342370 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10342370 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:10342370 | pubmed:issn | 0271-3683 | lld:pubmed |
| pubmed-article:10342370 | pubmed:author | pubmed-author:ChengLL | lld:pubmed |
| pubmed-article:10342370 | pubmed:author | pubmed-author:HostetlerK... | lld:pubmed |
| pubmed-article:10342370 | pubmed:author | pubmed-author:FreemanW RWR | lld:pubmed |
| pubmed-article:10342370 | pubmed:author | pubmed-author:GardnerM FMF | lld:pubmed |
| pubmed-article:10342370 | pubmed:author | pubmed-author:Bergeron-Lynn... | lld:pubmed |
| pubmed-article:10342370 | pubmed:author | pubmed-author:AvilaC PCPJr | lld:pubmed |
| pubmed-article:10342370 | pubmed:author | pubmed-author:SeversonG MGM | lld:pubmed |
| pubmed-article:10342370 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10342370 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:10342370 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10342370 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10342370 | pubmed:pagination | 161-7 | lld:pubmed |
| pubmed-article:10342370 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:10342370 | pubmed:meshHeading | pubmed-meshheading:10342370... | lld:pubmed |
| pubmed-article:10342370 | pubmed:meshHeading | pubmed-meshheading:10342370... | lld:pubmed |
| pubmed-article:10342370 | pubmed:meshHeading | pubmed-meshheading:10342370... | lld:pubmed |
| pubmed-article:10342370 | pubmed:meshHeading | pubmed-meshheading:10342370... | lld:pubmed |
| pubmed-article:10342370 | pubmed:meshHeading | pubmed-meshheading:10342370... | lld:pubmed |
| pubmed-article:10342370 | pubmed:meshHeading | pubmed-meshheading:10342370... | lld:pubmed |
| pubmed-article:10342370 | pubmed:meshHeading | pubmed-meshheading:10342370... | lld:pubmed |
| pubmed-article:10342370 | pubmed:meshHeading | pubmed-meshheading:10342370... | lld:pubmed |
| pubmed-article:10342370 | pubmed:meshHeading | pubmed-meshheading:10342370... | lld:pubmed |
| pubmed-article:10342370 | pubmed:meshHeading | pubmed-meshheading:10342370... | lld:pubmed |
| pubmed-article:10342370 | pubmed:meshHeading | pubmed-meshheading:10342370... | lld:pubmed |
| pubmed-article:10342370 | pubmed:meshHeading | pubmed-meshheading:10342370... | lld:pubmed |
| pubmed-article:10342370 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10342370 | pubmed:articleTitle | Intravitreal pharmacokinetics in rabbits of the foscarnet lipid prodrug: 1-O-octadecyl-sn-glycerol-3-phosphonoformate (ODG-PFA). | lld:pubmed |
| pubmed-article:10342370 | pubmed:affiliation | Shiley Eye Center, UCSD, La Jolla, CA 92093, USA. | lld:pubmed |
| pubmed-article:10342370 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10342370 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
